HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

(3'R)-3'-(3-hydroxyphenyl)-4-methylspiro[1H-1,4-benzodiazepine-3,2'-oxirane]-2,5-dione

HCID 354161
New reaction
Print
Basic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
20007-85-6
Standard SMILES
CN1C(=O)c2ccccc2NC(=O)C12O[C@@H]2c1cccc(O)c1
InChIKey
BDDNYDPRCCDQQJ-XPCCGILXSA-N
Molecular formula
C17H14N2O4
Average molar mass
310.3 g/mol
Monoisotopic mass
310.09535693

Names & identifiers

Preferred name
(3'R)-3'-(3-hydroxyphenyl)-4-methylspiro[1H-1,4-benzodiazepine-3,2'-oxirane]-2,5-dione
IUPAC
(3'R)-3'-(3-hydroxyphenyl)-4-methylspiro[1H-1,4-benzodiazepine-3,2'-oxirane]-2,5-dione
English name
cyclopenol
Molecular formula
C17H14N2O4
Molecular weight
310.3

Names & synonyms

NSC604990CHEMBL1992260HB3858NCI60_004629Spiro[3H-1,2'-oxirane]-2,5(1H,4H)-dione, 3'-(3-hydroxyphenyl)-4-methyl-, cis-(-)-NSC 604990cyclopenolCyclophenol(–)-CyclopenolCyclopenol DISCONTINUED(-)-3'-(3-Hydroxyphenyl)-4-methylspiro[3H-1,4-benzodiazepine-3,2'-oxirane]-2,5(1H,4H)-dioneSpiro[3H-1,4-benzodiazepine-3,2'-oxirane]-2,5(1H,4H)-dione, 3'-(3-hydroxyphenyl)-4-methyl-, (2'S,3'R)-

Database identifiers

CAS
20007-85-6
PubChem CID
354161
ChEMBL
CHEMBL1992260

Properties

Computed structural properties

XLogP
1.1
Topological polar surface area
82.2 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
4
Rotatable bonds
1
Heavy atoms
23
Formal charge
0
Complexity
525

Physicochemical properties

Melting point
215 ℃ · 215℃ (decomposition)
Boiling point
633.2 · 633.2±55.0 °C(Predicted)
Density
1.5 · 1.50±0.1 g/cm3(Predicted)
storage temp.
-20 °C · -20°C
solubility
DMSO: soluble; Ethanol: soluble; Methanol: soluble
form
A solid
pka
9.62 · 9.62±0.10(Predicted)
color
Off-white
Major Application
metabolomicsvitamins, nutraceuticals, and natural products
InChI
1S/C17H14N2O4/c1-19-15(21)12-7-2-3-8-13(12)18-16(22)17(19)14(23-17)10-5-4-6-11(20)9-10/h2-9,14,20H,1H3,(H,18,22)/t14-,17+/m1/s1
InChIKey
BDDNYDPRCCDQQJ-PBHICJAKSA-N
SMILES
N1([C@@]3(O[C@@H]3c4cc(ccc4)O)C(=O)Nc2c(cccc2)C1=O)C
FDA UNII
4 Q2498L80A · 4Q2498L80A
UNSPSC Code
12352205 · 12352205
NACRES
25 · NA.25
Symbol(GHS)
7 · GHS07,GHS09
Signal word
Warning
Hazard statements
302 · H302-H410
Precautionary statements
273 · P273-P501
Hazard Codes
Xn,N
Risk Statements
22 · 22-50
Safety Statements
61 · 61
RIDADR
3077 · UN 3077 9 / PGIII
WGK Germany
3 · 3
Storage Class
11 · 11 - Combustible Solids
Hazard Classifications
4 OralAquatic · Acute Tox. 4 OralAquatic Acute 1Aquatic Chronic 1

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

wgk
3
ridadr
UN 3077 9 / PGIII
risk_code
22-50
Signal word
Warning
Symbol(GHS)
GHS07,GHS09
hazard_code
Xn,N
safety_code
61
Storage Class
11 - Combustible Solids
Hazard statements
H302-H410
Hazard Classifications
Acute Tox. 4 OralAquatic Acute 1Aquatic Chronic 1
Precautionary statements
P273-P501

Chemistry & industry

Applications

Usesmetabolomicsvitamins, nutraceuticals, and natural products

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes